Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma

Cao,C. X.; Yang,X. C.; Gao,Y. X.; Zhuang,M.; Wang ,K. P.; Sun,L. J.; Wang,X. S.

doi:10.3892/ijmm.2012.1144

Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma

Authors:
- C. X. Cao
- X. C. Yang
- Y. X. Gao
- M. Zhuang
- K. P. Wang
- L. J. Sun
- X. S. Wang
View Affiliations

Affiliations: Department of Endocrinology, The Affiliated Hospital of the Medical College of Qingdao University, Shandong, Qingdao 266100, P.R. China, Department of Urology, The Affiliated Hospital of the Medical College of Qingdao University, Shandong, Qingdao 266100, P.R. China, Department of Nephrology, The Affiliated Hospital of the Medical College of Qingdao University, Shandong, Qingdao 266100, P.R. China
Published online on: September 27, 2012 https://doi.org/10.3892/ijmm.2012.1144
Pages: 1396-1402

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression of aldosterone synthase (CYP11B2), adrenocorticotropic hormone receptor (ACTH-R) and their regulating transcription factors in adrenal incidentalomas (AIs) from normotensive and hypertensive patients to distinguish subclinical or atypical primary aldosteronism (PA) from AIs. Total RNA was extracted from 8 normal adrenal cortices (NAs), 46 AIs, 15 aldosterone-producing adenomas (APAs) and 6 idiopathic hyperaldosteronisms (IHAs). Real-time quantitative polymerase chain reaction (PCR) and immunohistochemistry were performed to determine the mRNA and protein expression of CYP11B2, ACTH-R, steroidogenic factor-1 (SF1) and dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene-1 (DAX-1) in the different tissues. The AI hypertensive subgroup displayed increased plasma aldosterone concentration (PAC) and PAC/PRA ratio (ARR) and decreased plasma renin activity (PRA) compared to the normotensive group. CYP11B2, ACTH-R and SF1 mRNAs were signiﬁcantly higher in the APA group compared to the other groups, and gradually increased in AI hypertensive samples. DAX-1 mRNA was expressed faintly in PA compared with NA. In normotensive-AI samples, DAX-1 mRNA was higher compared to PA and AI hypertensive samples. Significant differences in gene expression levels in AIs were observed between probable and improbable PA patients. Immunohistochemical results were consistent with those of real-time PCR. Plasma aldosterone levels were positively correlated with CYP11B2, ACTH-R and SF1 mRNA and inversely correlated with DAX-1 mRNA. In conclusion, a significant number of hypertensive-AI patients may have subclinical forms of PA. CYP11B2, ACTH-R and their regulating transcription factors may be noteworthy in distinguishing subclinical PA from AIs.

View Figures

View References

1.	B BülowS JanssonC JuhlinAdrenal incidentaloma - follow-up results from a Swedish prospective studyEur J Endocrinol154419423200616498055
2.	S DoumaK PetidisM DoumasPrevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational studyLancet37119211926200810.1016/S0140-6736(08)60834-X18539224
3.	S MonticoneA ViolaD TizzaniPrimary aldosteronism: who should be screened?Horm Metab Res44163169201210.1055/s-0031-129540922120135
4.	Y ItoR TakedaS KarashimaPrevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjectsHypertens Res3498102201110.1038/hr.2010.16620927116
5.	A JoseNM KaplanPlasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertensionArch Intern Med123141146196910.1001/archinte.1969.003001200290045812600
6.	PF PlouinX JeunemaitreWould wider screening for primary aldosteronism give any health benefits?Eur J Endocrinol151305308200410.1530/eje.0.151030515362958
7.	RS VasanJC EvansMG LarsonSerum aldosterone and the incidence of hypertension in nonhypertensive personsN Engl J Med3513341200410.1056/NEJMoa03326315229305
8.	C MattssonWF Young JrPrimary aldosteronism: diagnostic and treatment strategiesNat Clin Pract Nephrol2198208200610.1038/ncpneph015116932426
9.	WF Young JrMinireview: primary aldosteronism - changing concepts in diagnosis and treatmentEndocrinology14422082213200310.1210/en.2003-027912746276
10.	MH BassettB MayhewK RehmanExpression profiles for steroidogenic enzymes in adrenocortical diseaseJ Clin Endocrinol Metab9054465455200510.1210/jc.2005-083615985477
11.	JM ConnellR FraserSM MacKenzieThe impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulationMol Cell Endocrinol217243247200410.1016/j.mce.2003.10.02515134824
12.	P YeB MarinielloF ManteroG-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronismJ Endocrinol1953948200710.1677/JOE-07-003717911395
13.	L LenziniTM SecciaE AldighieriHeterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysisHypertension5011061113200710.1161/HYPERTENSIONAHA.107.10043817938379
14.	K Saner-AmighBA MayhewF ManteroElevated expression of luteinizing hormone receptor in aldosterone-producing adenomasJ Clin Endocrinol Metabol9111361142200610.1210/jc.2005-129816332935
15.	T WangF SatohR MorimotoGene expression profiles in aldosterone-producing adenomas and adjacent adrenal glandsEur J Endocrinol164613619201110.1530/EJE-10-108521248073
16.	O ZwermannDM SchulteM ReinckeF BeuschleinACTH 1–24 inhibits proliferation of adrenocortical tumors in vivoEur J Endocrinol1534354442005
17.	S BoulkrounB Samson-CouterieJF Golib-DzibAldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markersEndocrinology15247534763201110.1210/en.2011-120521971159
18.	H ShibataY IkedaT MukaiExpression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesisMol Genet Metab74206216200110.1006/mgme.2001.323111592817
19.	P ValAM Lefrançois-MartinezG VeyssièreA MartinezSF-1 a key player in the development and differentiation of steroidogenic tissuesNucl Recept18200310.1186/1478-1336-1-814594453
20.	M ReinckeF BeuschleinAC LatronicoExpression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expressionClin Endocrinol (Oxf)46619626199710.1046/j.1365-2265.1997.1991009.x9231058
21.	A LacroixI BourdeauA LampronAberrant G-protein coupled receptor expression in relation to adrenocortical over-functionClin Endocrinol (Oxf)73115201019719763
22.	O ZwermannF BeuschleinE LalliClinical and molecular evidence for DAX-1 inhibition of steroidogenic factor-1-dependent ACTH receptor gene expressionEur J Endocrinol152769776200510.1530/eje.1.0190815879363
23.	KL ParkerBP SchimmerSteroidogenic factor 1: a key determinant of endocrine development and functionEndocrine Rev18361377199710.1210/edrv.18.3.03019183568
24.	H SasanoS ShizawaT SuzukiTranscription factor adrenal 4 binding protein as a marker of adrenocortical malignancyHum Pathol2611541156199510.1016/0046-8177(95)90280-57557951
25.	S SbieraS SchmullG AssieHigh diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumorsJ Clin Endocrinol Metab95E161E171201010.1210/jc.2010-065320660055
26.	J OuyangD HuB WangDifferential effects of down-regulated steroidogenic factor-1 on basal and angiotensin II-induced aldosterone secretionJ Endocrinol Invest34671675201121169726
27.	D HuJ OuyangZ WuElementary studies on elevated steroidogenic factor-1 expression in aldosterone-producing adenomaUrol Oncol30457462201210.1016/j.urolonc.2010.03.00120875752
28.	E ZazopoulosE LalliDM StoccoDNA binding and transcriptional repression by DAX-1 blocks steroidogenesisNature390311315199710.1038/368999384387
29.	E LalliMH MelnerDM StoccoP Sassone-CorsiDAX-1 blocks steroid production at multiple levelsEndocrinology1394237424319989751505
30.	M ReinckeF BeuschleinE LalliDAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesisJ Clin Endocrinol Metab8325972600199810.1210/jcem.83.7.50959661652
31.	M ReinckeF BeuschleinM SlawikK BormMolecular adrenocortical tumourigenesisEur J Clin Invest30Suppl 3S63S68200010.1046/j.1365-2362.2000.0300s3063.x
32.	T KonoF IkedaF OsekoNormotensive primary aldosteronism: report of a caseJ Clin Endocrinol Metab5210091013198110.1210/jcem-52-5-10096262353